Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 2
1(14.3%)
7Total
N/A(6)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05460520Not ApplicableRecruiting

DevRobust Treatment for Mal de Débarquement Syndrome

Role: collaborator

NCT04026633Not ApplicableCompleted

Attitudes & College Experiences

Role: lead

NCT04749719Not ApplicableUnknown

At Home Brain Stimulation Studies of Memory and Memory Awareness

Role: lead

NCT03453073Completed

Chocolate and CVD Risk in Postmenopausal Women

Role: lead

NCT03693729Not ApplicableUnknown

Effects of Brain-stimulation on Metamemory Monitoring and Control

Role: lead

NCT02334098Phase 2Completed

Omega-3 Supplementation and Behavior Problems

Role: collaborator

NCT02408289Not ApplicableCompleted

The Randomized Controlled Cocoa-Appetite Trial

Role: lead

NCT00950898Not ApplicableCompleted

The Acute Effects of Coffee on Glucose Metabolism

Role: lead

All 8 trials loaded